Vanoprazan Kit Manufacturer, Exporter, and Supplier in India
Combi pack of Vonoprazan Tablets, Levofloxacin Tablets & Amoxicillin Capsules
Discover H. pylori regimens containing a novel class of acid suppression: The first PCAB (potassium‑competitive acid blocker).
Each Kit Contains:
- 2 Vonoprazan Tablets 20 mg
- 2 Levofloxacin Tablets USP 500 mg
- 4 Amoxicillin Capsules BP 500 mg
This therapeutic intervention addresses infections stemming from Helicobacter pylori bacteria. This microorganism is known to induce gastric and intestinal ulcers, along with inflammation and edema of the gastric mucosa. Furthermore, it has been associated with an elevated propensity for gastric malignancies. Mitigating this infection serves to ameliorate ulcerative conditions and mitigate the potential for severe gastroduodenal mucosal compromise, including hemorrhage and perforation.
Vonoprazan functions as a proton pump inhibitor, effectively curtailing gastric acid secretion. This action holds the potential to expedite ulcer healing by diminishing the excess acid-mediated insult. Meanwhile, amoxicillin, a penicillin-class antibiotic, and levofloxacin, a fluoroquinolone-class antibiotic, are antibiotics with a broad spectrum of activity, encompassing H. pylori infections. Addressing the underlying bacterial infection not only promotes ulcer resolution but also diminishes the probability of recurrence.
Amoxicillin and levofloxacin exert their antimicrobial effects by impeding bacterial proliferation. Notably, their mode of action pertains exclusively to bacterial agents, without efficacy against viral pathogens such as those causing the common cold or influenza. Prudent utilization of antibiotics is imperative, as their gratuitous use may engender diminished responsiveness in subsequent infectious encounters.
* The above image provided is only for indicative and reference purpose.